• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sarcopenia: Performance of the SARC-F Questionnaire According to the European Consensus Criteria, EWGSOP1 and EWGSOP2.

作者信息

Hajaoui Manon, Locquet Médéa, Beaudart Charlotte, Reginster Jean-Yves, Petermans Jean, Bruyère Olivier

机构信息

World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.

Geriatric Department, CHU of Liège, Liège, Belgium.

出版信息

J Am Med Dir Assoc. 2019 Sep;20(9):1182-1183. doi: 10.1016/j.jamda.2019.05.021.

DOI:10.1016/j.jamda.2019.05.021
PMID:31455509
Abstract
摘要

相似文献

1
Sarcopenia: Performance of the SARC-F Questionnaire According to the European Consensus Criteria, EWGSOP1 and EWGSOP2.肌肉减少症：根据欧洲共识标准（EWGSOP1和EWGSOP2）评估SARC-F问卷的表现
J Am Med Dir Assoc. 2019 Sep;20(9):1182-1183. doi: 10.1016/j.jamda.2019.05.021.
2
Evaluating sarcopenia prevalence and SARC-F effectiveness in elderly Spanish women with RA: a comparative study of EWGSOP criteria.评估西班牙老年类风湿关节炎女性患者的肌少症患病率及SARC-F有效性：一项基于欧洲老年人肌肉减少症工作组（EWGSOP）标准的比较研究
Front Med (Lausanne). 2024 May 10;11:1392604. doi: 10.3389/fmed.2024.1392604. eCollection 2024.
3
Sarcopenia screening in elderly with Alzheimer's disease: performances of the SARC-F-3 and MSRA-5 questionnaires.阿尔茨海默病老年患者肌少症筛查：SARC-F-3 和 MSRA-5 问卷的表现。
BMC Geriatr. 2022 Sep 17;22(1):761. doi: 10.1186/s12877-022-03441-5.
4
Accuracy of SARC-F and SARC-CalF for sarcopenia screening in older women from southern Brazil.SARC-F 和 SARC-CalF 筛查巴西南部老年女性肌少症的准确性。
Nutrition. 2020 Nov-Dec;79-80:110955. doi: 10.1016/j.nut.2020.110955. Epub 2020 Jul 24.
5
Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review.根据 EWGSOP1 和 EWGSOP2 诊断老年人肌少症的流行率及其与不良健康结局的相关性：系统评价。
Aging Clin Exp Res. 2022 Mar;34(3):505-514. doi: 10.1007/s40520-021-01951-7. Epub 2021 Aug 16.
6
Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients.应用新的 EWGSOP2 指南而非旧的 EWGSOP 指南对老年患者进行肌肉减少症病例发现的后果。
Age Ageing. 2019 Sep 1;48(5):719-724. doi: 10.1093/ageing/afz035.
7
(Dis) Agreement between the first and the recent European consensus on definition and diagnosis for sarcopenia in kidney transplant patients.(肌肉减少症)在首次和最近的欧洲共识中对于肾移植患者定义和诊断的不一致。
Eur J Clin Nutr. 2020 Jul;74(7):1104-1108. doi: 10.1038/s41430-019-0535-5. Epub 2019 Nov 25.
8
Low Agreement Between Initial and Revised European Consensus on Definition and Diagnosis of Sarcopenia Applied to People Living With HIV.初始和修订的欧洲共识对肌少症的定义和诊断标准在 HIV 感染者中的应用具有低一致性。
J Acquir Immune Defic Syndr. 2021 Apr 1;86(4):e106-e113. doi: 10.1097/QAI.0000000000002576.
9
EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences.EWGSOP2 与 EWGSOP1 的比较：对肌肉减少症患病率及其主要健康后果的影响
J Am Med Dir Assoc. 2019 Mar;20(3):384-385. doi: 10.1016/j.jamda.2018.11.027. Epub 2019 Jan 17.
10
Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study.SARC-F 问卷筛查的肌少症与老年女性的身体表现：一项横断面研究。
J Am Med Dir Assoc. 2017 Oct 1;18(10):848-852. doi: 10.1016/j.jamda.2017.05.010. Epub 2017 Jun 16.

引用本文的文献

1
Performance Evaluation of Machine Learning Algorithms for Sarcopenia Diagnosis in Older Adults.老年人肌肉减少症诊断中机器学习算法的性能评估
Healthcare (Basel). 2023 Oct 9;11(19):2699. doi: 10.3390/healthcare11192699.
2
Diagnostic performance of SARC-F and SARC-CalF in screening for sarcopenia in older adults in Northern Brazil.巴西北部老年人肌少症筛查中 SARC-F 和 SARC-CalF 的诊断性能。
Sci Rep. 2023 Jul 20;13(1):11698. doi: 10.1038/s41598-023-39002-y.
3
Different assessment tools to detect sarcopenia in patients with Parkinson's disease.
用于检测帕金森病患者肌肉减少症的不同评估工具。
Front Neurol. 2022 Nov 28;13:1014102. doi: 10.3389/fneur.2022.1014102. eCollection 2022.
4
Association of SARC-F Score and Rockwood Clinical Frailty Scale with CT-Derived Muscle Mass in Patients with Aortic Aneurysms.SARC-F 评分和 Rockwood 临床虚弱量表与主动脉瘤患者 CT 衍生肌肉量的相关性。
J Nutr Health Aging. 2022;26(8):792-798. doi: 10.1007/s12603-022-1828-2.
5
Prevalence and factors associated with poor performance in the 5-chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of sarcopenia.5 椅站立测试表现不佳的患病率及相关因素：来自认知功能和衰老研究 II 的结果和拟用于评估肌少症的纽卡斯尔方案。
J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):308-318. doi: 10.1002/jcsm.12660. Epub 2021 Jan 18.
6
Towards Personalized Management of Sarcopenia in COPD.面向 COPD 患者肌少症的个体化管理。
Int J Chron Obstruct Pulmon Dis. 2021 Jan 7;16:25-40. doi: 10.2147/COPD.S280540. eCollection 2021.
7
Verification of the predictive validity for mortality of the SARC-F questionnaire based on a meta-analysis.基于荟萃分析验证 SARC-F 问卷对死亡率的预测效度。
Aging Clin Exp Res. 2021 Apr;33(4):835-842. doi: 10.1007/s40520-020-01585-1. Epub 2020 May 25.